ClinicalTrials.Veeva

Menu

Ticagrelor vs Clopidogrel for Platelet Inhibition in Stenting for Cerebral Aneurysm (TIC-TAC)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status and phase

Completed
Phase 3

Conditions

Cerebral Aneurysm

Treatments

Drug: Ticagrelor
Drug: aspirin
Drug: Clopidogrel

Study type

Interventional

Funder types

NETWORK

Identifiers

NCT02675205
2014-005720-10 (EudraCT Number)
AGR_2014-33

Details and patient eligibility

About

Part of interventional neuroradiology procedures for the treatment of selected cerebral aneurysms are now based on stenting. To reduce thromboembolic events, dual antiplatelet therapy (APT) combining aspirin and clopidogrel is proposed with close monitoring, since 1/3 of the patients are low responders due to variation of the biological response to clopidogrel . Ticagrelor is used by few teams but has never been evaluated in a randomized controlled trial. It could be an option for APT due to more reproducible response with less interindividual variability and reduced monitoring. The aim of this study is to demonstrate the interest of ticagrelor for the dual APT for platelet inhibition, in patients undergoing neurovascular stenting for cerebral aneurysm.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • unruptured cerebral aneurysm
  • elective endovascular treatment
  • stenting required
  • dual antiplatelet therapy required

Exclusion criteria

-none

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

clopidogrel-aspirin
Active Comparator group
Description:
clopidogrel: 75mg and aspirin 250 mg once a day for 15 weeks; prescribed 3 weeks before surgery.
Treatment:
Drug: Clopidogrel
Drug: aspirin
ticagrelor-aspirin
Experimental group
Description:
Ticagrelor: 90 mg bid and aspirin 250 mg once a day for 15 weeks; prescribed 3 weeks before surgery
Treatment:
Drug: aspirin
Drug: Ticagrelor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems